From: Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer
Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
Coefficient | Hazard ratio | P | Coefficient | Hazard ratio | P | |
Training cohort | ||||||
Risk score | 1 | 2.718 (1.741–4.244) | < 0.001 | 1.071 | 2.917 (1.549–5.492) | 0.001 |
Age | 0.02 | 1.020 (1.004–1.037) | 0.015 | 0.018 | 1.018 (1.001–1.035) | 0.037 |
Grade | 0.066 | 1.068 (0.787–1.448) | 0.673 | − 0.109 | 0.896 (0.637–1.263) | 0.532 |
Figo_stage | 0.359 | 1.432 (0.981–2.089) | 0.062 | 0.398 | 1.489 (0.980–2.262) | 0.062 |
Validation cohort | ||||||
Risk score | 0.949 | 2.583 (1.335–4.994) | 0.005 | 0.853 | 2.347 (1.189–4.633) | 0.014 |
Age | 0.023 | 1.023 (0.997–1.05) | 0.087 | 0.023 | 1.023 (0.996–1.051) | 0.096 |
Grade | 0.242 | 1.274 (0.752–2.159) | 0.368 | 0.146 | 1.157 (0.646–2.073) | 0.624 |
Figo_stage | 0.051 | 1.052 (0.679–1.630) | 0.819 | 0.211 | 1.235 (0.750–2.033) | 0.407 |